CoChat

Kigamicin D, a novel anticancer agent based on a new anti‐austerity strategy targeting cancer cells' tolerance to nutrient starvation

Open access
Lu, Jie, Kunimoto, Setsuko, Yamazaki, Yohko, Kaminishi, Michio, Esumi, Hiroyasu · 2004 · Cancer Science
Cited by 107

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Both tolerance to nutrient starvation and angiogenesis are esse tial for cancer progression because of the insufficient supply of nutrients to tumor tissue. Since chronic nutrient starvation seldom occurs in normal tissue, cancer's tolerance to nutrient starvation should provide a novel target for cancer therapy. In this study, we propose an anti‐austerity strategy to exploit the ability of agents to eliminate cancer cells' tolerance to nutrient starvation. We established a simple screening method for agents that inhibit cancer cell viability preferentially during nutrient starvation, using PANC‐1 cell line cultured in nutrient‐rich and nutrien deprived media. After screening over 2000 culture media of act nomycetes, we identified a new compound, kigamicin (C 48 H 59 NO 19), which shows preferential cytotoxicity to cancer ceels under nutrient‐deprived conditions, but hardly any cytotoxici under nutrient‐rich conditions. Both subcutaneous and oral a ministration of kigamicin D strongly suppressed the tumor growth of several tested pancreatic cancer cell lines in nude mice Moreover, kigamicin D was observed to block the activation of Akt induced by nutrient starvation. Therefore, our results sugge that kigamicin D be a candidate for implementing our novel concept, anti‐austerity, which may serve as a new strategy for cancer therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1349-7006.2004.tb03247.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 107

Metadata

Authors
Lu, J., Kunimoto, S., Yamazaki, Y., Kaminishi, M., & Esumi, H.
Venue
Cancer Science
Publisher
Wiley
Published
2004-06
Volume
95
Issue
6
Pages
547-552
ISSN
  • 1347-9032 (ISSN-L)
  • 1349-7006
OpenAlex
W2015421371
Cited by
107
References
1
FWCI
1.31
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Kigamicin D, a novel anticancer agent based on a new anti‐austerity strategy targeting cancer cells' tolerance to nutrient starvation. https://app.cochat.ai/papers/10.1111/j.1349-7006.2004.tb03247.x
The paper
Lu, J., Kunimoto, S., Yamazaki, Y., Kaminishi, M., & Esumi, H. (2004). Kigamicin D, a novel anticancer agent based on a new anti‐austerity strategy targeting cancer cells' tolerance to nutrient starvation. Cancer Science. https://doi.org/10.1111/j.1349-7006.2004.tb03247.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.